Press
Gnosis by Lesaffre welcomes the opportunity to engage with the media about the impact of our clinically proven MenaQ7® can have on the state of global health.
Press inquiries can be directed to Kate Quackenbush, Communications Director:
K.QUACKENBUSH@gnosis.lesaffre.com